Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Anti-O-linked N-acetylglucosamine (O-GlcNAc) Monoclonal Antibodies (23 lines)


Detailed Technology Description

These mouse monoclonalantibodies were generated against a synthetic three-component O-linkedN-acetylglucosamine (O-GlcNAc) immunogen and recognizes GluNAcpepetide/O-GlcNAc. Suitable for ELISA and Western Blot applications. The study of O-GlcNAc,a ubiquitous translation and transcription regulator which is found in a widevariety of proteins, is of great relevance to multiple chronic human andveterinary diseases. These include diabetes (and its effects in the heart,kidneys and eyes), cardiovascular disease, neurodegenerative disordersinvolving both plaque and tangle formation, inflammatory processes, liverdisease, fibrosis, metabolic disorders and cancer. There is fast growingcollection of evidence that O-GlcNAcylation plays a pivotal role in epigenetics.This  a 23 Mab panel was developedspecifically to study the diverse roles of O-GlcNAc and that can be employedfor detection, isolation, and site localization. For details on antigenstrategy, please consult: Chin Fen Teo, et al., Nat Chem Biol. 2010 May; 6(5):338-343. doi:10.1038/nchembio.338 (see link below).


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View